Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: AZD9668 Relative Bioavailability [Phase 1]
A Phase 1 study evaluating the relative bioavailability of AZD9668 in Chronic Obstructive Pulmonary Disease patients.
-
FDA approval · 2013-01-25FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Dulera (mometasone furoate and formoterol fumarate dihydrate) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Effects of an Air Purifying Device (PureNight) on Sleep Quality in Obstructive Lung Disease [NA]
The trial updates and reports on the effects of the PureNight air-purifying device on sleep quality in chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS research · 2013-01-23Clinical Trial Update: Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD) [Phase 2, Phase 3]
This document notes the completion of a Phase 2/Phase 3 clinical trial investigating palliation of dyspnea in advanced chronic obstructive p…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: A Study to Assess the Long-term Safety of QVA149 [Phase 3]
A Phase 3 long-term safety study of QVA149 (indacaterol/glycopyrronium) in chronic obstructive pulmonary disease has completed and results h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 dose-ranging trial evaluating four doses of indacaterol delivered via the TWISTHALER device in chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients [Phase 3]
Phase 3 long-term safety and tolerability comparison of NVA237 (glycopyrronium) versus tiotropium in Japanese COPD patients completed; resul…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study [Phase 4]
A Phase 4 COPD post-hospitalization trial sponsored by GlaxoSmithKline has completed and posted results in 2013.
-
FDA approval · 2013-01-15FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Dulera (mometasone furoate and formoterol fumarate dihydrate) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Asthma & COPD Guideline Implementation [EARLY_Phase 1]
Early-phase (Phase 1) trial update on implementing asthma and chronic obstructive pulmonary disease guideline practices; the study is termin…
-
FDA approval · 2013-01-09FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate), resulting in an approved labeling upda…
-
FDA approval · 2013-01-09FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) from Boehringer Ingelheim Pharmaceuti…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing
This clinical trial update analyzes how bag volume variation affects the reproducibility of the inert gas rebreathing method used for pulmon…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]
A Phase 3 trial update evaluating the safety and efficacy of daily 18 µg formoterol (9 µg twice daily) in Japanese chronic obstructive pulmo…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Effects of Aerobe Interval Training and Moderate Continuous Training in Chronic Obstructive Pulmonary Disease Patients [NA]
A completed clinical trial comparing aerobic interval training with moderate continuous training in patients with chronic obstructive pulmon…
-
CLINICAL_TRIALS research · 2012-12-25Clinical Trial Update: Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating acetylsalicylic acid (aspirin) for the treatment of chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Rehabilitation in Chronic Obstructive Pulmonary Disease Outpatients
A completed clinical trial update on rehabilitation in outpatients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Does Pulmonary Rehabilitation Change Self-Selected And Maximum Sustainable Walking Speed In Patients With Lung Disease? [NA]
This clinical trial update investigates whether pulmonary rehabilitation changes self-selected and maximum sustainable walking speed in pati…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: SMS Reminder to Assess Adherence
A completed Boehringer Ingelheim COPD trial evaluated using SMS reminders to assess medication adherence; results were posted in 2012.
-
FDA approval · 2012-12-19FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) from GlaxoSmithKline LLC, indicatin…
-
FDA approval · 2012-12-18FDA Approved: DALIRESP — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Daliresp (rofllumilast) from AstraZeneca Pharmaceuticals LP, resulting in an updated product…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD [NA]
A completed clinical trial evaluated whether the fluticasone/salmeterol combination affects exertional breathlessness in patients with mild …
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial studying exercise endurance and lung hyperinflation in patients with moderate to severe chronic obstructive pulmonary disease …
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics
A completed clinical trial from the University of Pittsburgh investigates genetic factors that influence chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Study of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations In Spain
A Cimera-sponsored trial evaluating chronic obstructive pulmonary disease (COPD) exacerbations in Spain has completed.